4Ooi A, Takehana T, Li X, et al. Protein overexpression and gene amplification of HER-2 and EGFR in colorcctal cancers an inmunohistochemical and fluorescent in situ hybridization study [J]. Mod Pathol,2004,17(8) :895-904. 被引量：1
5Knosel T, Yu Y, Stein L, et al. Overexpression of c-erbB-2 protein correlates with chromosomal gain at the c-erbB-2 locus and patient survival in advanced colorectal carcinomas[J]. Clin Exp Metastasis,2002,19(5) :401-407. 被引量：1
3McKay JA,Loane JF,Ross VG,et al.c-erbB-2 is not a major factor in the development of colorectal cancer[J].Br J Cancer,2002,86(4):568-573. 被引量：1
4D'Emilia J,Bulovas K,D'Ercole K,et al.Expression of the c-erbB-2 gene product (p185) at different stages of neoplastic progression in the colon[J].Oncogene,1989,4(10):1233-1239. 被引量：1
5Had ija MP,Kapitanovic S,Radosevic S,et al.Loss of heterozygosity of DPC4 tumor suppressor gene in human sporadic colon cancer[J].J Mol Med,2001,79(2):128-132. 被引量：1
6MacGrogan D,Pegram M,Slamon D,et al.Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas[J].Oncogene,1997,15(9):1111-1114. 被引量：1
7Ohtaki N,Yamaguchi A,Goi T,et al.Somatic alterations of the DPC4 and Madr2 genes in colorectal cancers and relationship to metastasis[J].Int J Oncol,2001,18(2):265-270. 被引量：1
8Zhang R,Takahashi S,Orita S,et al.p53 gene mutations in rectal cancer associated with schistosomiasis japonica in Chinese patients[J].Cancer Lett,1998,131(2):215-221. 被引量：1
9Ooi A,Takehana T,Li X,et al.Protein overexpression and gene amplification of HER-2 and EGFR in colorectal cancers:an immunohistochemical and fluorescent in situ hybridization study[J].Mod Pathol,2004,17(8):895-904. 被引量：1
10Soliman AS,Bondy ML,EI-Badawy SA,et al.Contrasting molecular pathology of colorectal carcinoma in Egyptian and western patients[J].Br J Cancer,2001,85(7):1037-1046. 被引量：1
5Okamura H,Tsutsi H,Komatsu T. Cloning of a new cytokine that induces IFN-gamma production by T cells[J].{H}NATURE,1995,(6552):88-91. 被引量：1
6Lewkowich IP,Hay Glass KT. Endogenous IFN-gamma and IL-18 pro-duction directly limit induction of type 2 immunity in vivo[J].{H}European Journal of Immunology,2002,(12):3536-3545. 被引量：1
7Nakanishi K,Yoshinoto T,Tsutsui H. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu[J].Cytokine Grow Factor Rev,2001,(01):53-72. 被引量：1
8Wong CK,Ho AM,Tong PC. Aberrant activation profile of cytokines and mitogen-activated protein kinases in type 2 diabetic patients with nephropathy[J].Clini Exp Immunol,2007,(01):123-131. 被引量：1
9Smyth DJ,Plagnol V,Walker NM. Shared and distinct genetic variants in type 1 diabetes and celiac disease[J].{H}New England Journal of Medicine,2008,(26):2767-2777. 被引量：1
10Zhernakova A,Festen EM,Franke L. Genetic analysis of innate immunity in Croh's disease and ulcerative colitis identifies two loci harboring CARD9 and IL18RAP[J].{H}American Journal of Hunan Genetics,2008,(05):1202-1210. 被引量：1
